{"id":480,"date":"2015-03-30T17:07:38","date_gmt":"2015-03-30T21:07:38","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=480"},"modified":"2015-03-30T17:07:38","modified_gmt":"2015-03-30T21:07:38","slug":"secondaries-announced-3-30-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-3-30-2015\/","title":{"rendered":"Secondaries announced 3.30.2015"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating.<\/p>\n<p>Company: Mylan N.V.<br \/>\nSymbol: MYL<br \/>\nPrice: Last trade $61.63<br \/>\nTrade Date: 4\/1<br \/>\nShares: 35 million<br \/>\nUnderwriter(s) Morgan Stanley, Goldman Sachs<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: CyrusOne Inc.<br \/>\nSymbol: CONE<br \/>\nPrice: Last trade $32.52<br \/>\nTrade Date: 4\/1<br \/>\nShares: 12.2 million<br \/>\nUnderwriter(s) Citigroup, Morgan Stanley, Barclays, Deutsche Bank Securities, Goldman Sachs, J.P. Morgan<br \/>\nCo Manager(s) PNC Capital Markets, Regions Securities, UBS Investment Bank<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Synta Pharmaceuticals Corp.<br \/>\nSymbol: SNTA<br \/>\nPrice: Last trade $2.33<br \/>\nTrade Date: 3\/31<br \/>\nShares: 15 million<br \/>\nUnderwriter(s) Jefferies, Cowen &amp; Co.<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Trillium Therapeutics<br \/>\nSymbol: TRIL<br \/>\nPrice: Last trade $19.65<br \/>\nTrade Date: 4\/1<br \/>\nShares: 2.5 million<br \/>\nUnderwriter(s) Leerink Partners, Cowen &amp; Co.<br \/>\nCo Manager(s) Oppenheimer &amp; Co.<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Coherus Biosciences<br \/>\nSymbol: CHRS<br \/>\nPrice: Last trade $30.08<br \/>\nTrade Date: 4\/1<br \/>\nShares: 3.3 million<br \/>\nUnderwriter(s) J.P. Morgan, Credit Suisse, Cowen &amp; Co.<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Insmed<br \/>\nSymbol: INSM<br \/>\nPrice: Last trade $21.09<br \/>\nTrade Date: 3\/31<br \/>\nShares: 10 million<br \/>\nUnderwriter(s) Citigroup, Leerink Swann<br \/>\nCo Manager(s) JMP Securities, H.C. Wainwright<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Axalta Coating Systems Ltd.<br \/>\nSymbol: AXTA<br \/>\nPrice: Last trade $27.32<br \/>\nTrade Date: 4\/2<br \/>\nShares: 35 million<br \/>\nUnderwriter(s) Citigroup, Goldman Sachs, Deutsche Bank, J.P. Morgan, BofA Merrill Lynch, Barclays, Jefferies, UBS Investment Bank<br \/>\nCo Manager(s) Morgan Stanley, BB&amp;T Capital Markets, Nomura, SMBC Nikko<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Cerulean Pharma Inc.<br \/>\nSymbol: CERU<br \/>\nPrice: Last trade $9.50<br \/>\nTrade Date: 4\/2<br \/>\nShares: 5.3 million<br \/>\nUnderwriter(s) Leerink Partner, Barclays Capital<br \/>\nCo Manager(s) Canaccord Genuity, JMP Securities, Wedbush PacGrow<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Raptor Pharmaceuticals<br \/>\nSymbol: RPTP<br \/>\nPrice: Last trade $12.04<br \/>\nTrade Date: 4\/2<br \/>\nShares: 6.2 million<br \/>\nUnderwriter(s) Citigroup, Leerink Partners, Cowen &amp; Co., JMP Securities<br \/>\nCo Manager(s) Janney Montgomery Scott<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Media General, Inc.<br \/>\nSymbol: MEG<br \/>\nPrice: Last trade $16.79<br \/>\nTrade Date: 4\/1<br \/>\nShares: 6.8 million<br \/>\nUnderwriter(s) RBC Capital Markets, Evercore ISI<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Mylan N.V. Symbol: MYL Price: Last trade $61.63 Trade Date: 4\/1 Shares: 35 million Underwriter(s) Morgan Stanley, Goldman Sachs Rating=Subscription Needed[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[276,277,274,271,275,279,278,272,273],"class_list":["post-480","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-axta","tag-ceru","tag-chrs","tag-cone","tag-insm","tag-meg","tag-rptp","tag-snta","tag-tril"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=480"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/480\/revisions"}],"predecessor-version":[{"id":481,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/480\/revisions\/481"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}